The DRDO, along with its industry partner DRL, Hyderabad, started the clinical trials to test the safety and efficacy of the drug in Covid-19 patients. In Phase-II trials (including dose ranging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback